Are you Dr. Shrivastava?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 7 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
737 Park Ave
Suite 1a
New York, NY 10021Phone+1 212-288-0138Fax+1 212-288-3544- Is this information wrong?
Summary
- Dr. Ram Shrivastava, MD is a psychiatrist in New York, New York. He is currently licensed to practice medicine in New York and New Jersey.
Education & Training
Gandhi Medical CollegeClass of 1963
Certifications & Licensure
NJ State Medical License 1981 - Present
NY State Medical License 1981 - 2024
Clinical Trials
- Efficacy, Safety and Tolerability of CX157 in Treatment Resistant Depression Start of enrollment: 2010 Nov 01
- Genomics Used to Improve DEpression Decisions Start of enrollment: 2014 Apr 01
Publications & Presentations
PubMed
- 51 citationsImproved insomnia symptoms and sleep-related next-day functioning in patients with comorbid major depressive disorder and insomnia following concomitant zolpidem exten...Maurizio Fava, Gregory M. Asnis, Ram K. Shrivastava, Bruce Lydiard, Bijan Bastani, David V. Sheehan, Thomas Roth> ;The Journal of Clinical Psychiatry. 2011 Jul 1
- 37 citationsZolpidem extended-release improves sleep and next-day symptoms in comorbid insomnia and generalized anxiety disorder.Maurizio Fava, Gregory M. Asnis, Ram K. Shrivastava, Bruce Lydiard, Bijan Bastani, David V. Sheehan, Thomas Roth> ;Journal of Clinical Psychopharmacology. 2009 Jun 1
- 9 citationsEfficacy and safety of 30 mg/d and 45 mg/d nemifitide compared to placebo in major depressive disorderStuart Montgomery, John P. Feighner, Lev Sverdlov, Ram K. Shrivastava, Lynn A. Cunningham, Ari Kiev, Joseph J. Hlavka, George Tonelli> ;The International Journal of Neuropsychopharmacology. 2006 Oct 1
- Join now to see all
